Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib
収録刊行物
-
- Oncogene
-
Oncogene 35 (7), 878-886, 2015-05-11
Springer Science and Business Media LLC